About

Benjamin Jung, PhD, was Program Manager Connected Devices at H&T Presspart until 2019, where he was responsible for this innovative product segment, which includes H&T Presspart’s eMDI. He has a Diploma in Industrial Engineering from RWTH Aachen University (Germany) and a PhD in Strategic Management from University of Duisburg-Essen (Germany), where he focused on the radical technological change in the automotive industry – the transition to electric mobility. Dr Jung joined the Heitkamp & Thumann Group (H&T) in 2014, initially as the Assistant to the Management Board of the Group.

Contributions

CONNECTIVITY

THE FUTURE OF CONNECTED ASTHMA AND COPD CARE: A NETWORK PERSPECTIVE

Benjamin Jung uses a network theory approach to look at the ongoing issue of adherence when it comes to the treatment of asthma and COPD, and the players involved in overcoming it.

More contributions

CONNECTIVITY

THE FUTURE OF CONNECTED ASTHMA AND COPD CARE: A STEPWISE DEVELOPMENT

Benjamin Jung outlines possible scenarios for the likely steps in the development and adoption of connected devices in the field of asthma and COPD care.

CONNECTIVITY

EMBEDDED CONNECTED METERED DOSE INHALERS MEETING REQUIREMENTS FOR MASS ADOPTION

Benjamin Jung and Dana Shears describe the role connected devices can play in the treatment of asthma and COPD, discuss the requirements for mass adoption, and introduce H&T Presspart's inhaler, the eMDI, which has connectivity fully embedded.